Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Am Coll Surg. 2012 Oct 11;216(1):123–134. doi: 10.1016/j.jamcollsurg.2012.08.027

Figure 1.

Figure 1

Overall survival from time of first liver-directed operation for patients with hepatic neuroendocrine metastasis. Median overall survival was 125.1 months, with 5- and 10-year survival of 74 and 51%, respectively. (With kind permission from Springer Science+Business Media: Annals of Surgical Oncology, Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis, vol 17, 2010, pages 3129–3136, Mayo SC, de Jong MC, Pulitano C, et al, Figure 1 [7].)